Abstract
Objectives:
We aimed to assess the association between metabolic syndrome (MS) and hepatitis B/C virus infection using a large population-based study.
Design and methods:
A population-based cross-sectional study design was adopted with a total of 53 528 subjects being enrolled from the integrated multiple diseases screening program in Keelung, Taiwan. Evidence of past hepatitis B/C infection, acquired during childhood or as a young adult, was identified during the two-stage liver cancer screening part of the process. Information on biochemical markers and anthropometric measures related to MS, such as fasting blood sugar, triglyceride and high-density lipoprotein (HDL), abdominal circumference and blood pressure (BP), were collected routinely while screening for hypertension, type 2 diabetes, and hyperlipidemia. Logistic regression was used to estimate odds ratios and related 95% confidence intervals for the associations between MS and hepatitis B/C infection.
Results:
High blood pressure (SBP⩾135 mmHg or DBP⩾85 mmHg) (adjusted odd ratio: 0.89 (0.83–0.94)) and high triglyceride (⩾150 mg/dl) (adjusted odds ratio: 0.65 (0.60–0.69)) were, after adjusting for gender and age, inversely associated with being HBsAg positive (P<0.05). The likelihood of developing MS was lower in the HBsAg positive than the HBsAg negative (adjusted odds ratio: 0.84 (0.76–0.93)). A positive association between being anti-HCV positive and having low serum HDL (male <40 mg/dl, female <50 mg/dl) was also noted (adjusted odds ratio: 1.61 (1.37–1.88) after controlling for gender and age). High triglyceride was inversely associated with being anti-HCV positive (adjusted odds ratio: 0.63 (0.55–0.71).
Conclusions:
There is an inverse association between MS and hepatitis B virus infection whereas the association was heterogeneous for HCV infection with a positive association with abnormal serum HDL but an inverse association with hypertriglyceridemia.
Similar content being viewed by others
References
Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415–1428.
Kanel GC, Radvan G, Peters RL . High-density lipoprotein cholesterol and liver disease. Hepatology 1983; 3: 343–348.
Cicognani C, Malavolti M, Morselli-Labate AM et al. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997; 157: 792–796.
Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD . Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc 2004; 103: 286–291.
Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu-Dac N . High density lipoproteins facilitate hepatitis C virus entry through the Scavenger receptor class B type I. J Biol Chem 2005; 280: 7793–7799.
Huo TI, Wu JC, Lee PC, Tsay SH, Chang FY, Lee SD . Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. J Clin Gastroenterol 2000; 30: 250–254.
Sangiorgio L, Attardo T, Gangemi R, Rubino C, Barone M, Lunetta M . Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res Clin Pract 2000; 48: 147–151.
Lao TT, Tse KY, Chan LY, Tam KF, Ho LF . HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care 2003; 26: 3011–3016.
Fraser GM, Harman I, Meller N, Niv Y, Porath A . Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 1996; 32: 526–530.
Okan V, Araz M, Aktaran S, Karsligil T, Meram I, Bayraktaroglu Z et al. Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey. Int J Clin Pract 2002; 56: 175–177.
Bedarida G, D'Agostino F, Bianchi M, Susani G, Sangalli F, Fattorini A et al. Unexpected lower prevalence of HBsAg in diabetics than in controls (A study on 2465 patients). Ric Clin Lab 1982; 12: 409–415.
Ozyilkan E, Ozyilkan O, Firat D, Telatar H . Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1994; 73: 2002–2003.
Grimbert S, Valensi P, Levy-Marchal C, Perret G, Richardet JP, Raffoux C et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case–control study. Gastroenterol Clin Biol 1996; 20: 544–548.
Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A . Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clinic Proc 2000; 75: 355–359.
Wang CS, Wang ST, Yao WJ, Chang TT, Chou P . Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol 2003; 158: 1154–1160.
Arao M, Murase K, Kusakabe A, Yoshioka K, Fukuzawa Y, Ishikawa T et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003; 38: 355–360.
Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL . Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592–599.
Lecube A, Hernandez C, Genesca J, Esteban JI, Jardi R, Simo R . High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care 2004; 27: 1171–1175.
Mangia A, Schiavone G, Lezzi G, Marmo R, Bruno F, Villani MR et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998; 93: 2363–2367.
Sung JL, Chen DS, Lai MY, Yu JY, Wang TH, Wang CY et al. Epidemiological study on hepatitis B virus infection in Taiwan. Chinese J Gastroenterol 1984; 1: 1–9.
Chang MH, Lee CY, Chen DS . Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection. J Med Virol 1993; 40: 322–325.
Chen THH, Chiu YH, Luh DL, Yen MF, Wu HM, Chen LS et al. Taiwan Community-Based Integrated Screening Group Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 2004; 100: 1734–1743.
Beisel WR . Metabolic response to infection. Annu Rev Med 1975; 26: 9–20.
Grunfeld C, Feingold KR . Tumor necrosis factor, interleukin, and interferon induced changes in lipid, metabolism as part of host defense. Proc Soc Exp Biol Med 1992; 200: 224–227.
Fabris C, Federico E, Soardo G, Falleti E, Pirisi M . Blood lipids of patients with chronic hepatitis: differences related to viral etiology. Clin Chim Acta 1997; 261: 159–165.
Iannello S, Cavaleri A, Milazzo P, Cantarella S, Belfiore F . Low fasting serum triglyceride level as a precocious marker of autoimmune disorders. Med Gen Med 2003; 5: 20.
Takemura Y, Kobayashi H, Kamachi M, Sekiguchi S, Shioikari M, Tamura M . Pathogenesis-screening tests for liver dysfunction in the asymptomatic patients with elevated ALT values and their diagnostic efficacies in primary care medcine. Rinsho Byori 1996; 44: 261–266.
Wang CS, Chang TT, Chou P . Differing characteristics of hepatitis B and C risk factors among elders in a rural area in Taiwan. J Gerontol A Biol Sci Med Sci 1998; 53: M107–M111.
Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003; 18: 588–594.
Kang SK, Chung TW, Lee JY, Lee YC, Morton RE, Kim CH . The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J Biol Chem 2004; 279: 28106–28112.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jan, CF., Chen, CJ., Chiu, YH. et al. A population-based study investigating the association between metabolic syndrome and Hepatitis B/C infection (Keelung Community-based Integrated Screening Study No. 10). Int J Obes 30, 794–799 (2006). https://doi.org/10.1038/sj.ijo.0803204
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0803204
- Springer Nature Limited
Keywords
This article is cited by
-
Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection
Digestive Diseases and Sciences (2023)
-
The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
Egyptian Liver Journal (2021)
-
The association between serum alanine aminotransferase and hypertension: A national based cross-sectional analysis among over 21 million Chinese adults
BMC Cardiovascular Disorders (2021)
-
Infections at the nexus of metabolic-associated fatty liver disease
Archives of Toxicology (2021)
-
Association between Hepatitis B Virus Infection and Metabolic Syndrome in Southwest China: A Cross-sectional Study
Scientific Reports (2020)